Ocugen is trading 5.17% lower at $0.90, with no direct company-specific catalyst identified. - The biotech sector is under pressure, with XBI down 2.01% during the regular session; this weakness may be contributing to Ocugen’s larger decline. - The latest company press release found was dated October 6. Trading volume information was not provided.